PHASE II STUDY OF AMRUBICIN IN PATIENTS WITH REFRACTORY OR RESISTANT RELAPSED SMALL-CELL LUNG CANCER: JAPAN CLINICAL ONCOLOGY GROUP STUDY (JCOG0901)

被引：0
|
作者：
Daga, H. [1 ]
Murakami, H.
Yamamoto, N. [6 ]
Shibata, T. [3 ]
Endo, M. [2 ]
Watanabe, H. [4 ]
Ichinose, Y. [5 ]
Yamamoto, N. [6 ]
Ohe, Y. [7 ]
Tamura, T. [6 ]
机构：
[1] Osaka City Gen Hosp, Dept Clin Oncol, Osaka, Japan
[2] Shizuoka Canc Ctr, Dept Radiol, Shizuoka, Japan
[3] Natl Canc Ctr, Regulatory Sci Sect, Multiinst Clin Trial Support Ctr, Tokyo, Japan
[4] Natl Canc Ctr, Dept Radiol, Tokyo, Japan
[5] Kyushu Natl Canc Ctr, Dept Thorac Oncol, Fukuoka, Japan
[6] Natl Canc Ctr, Dept Thorac Oncol, Tokyo, Japan
[7] Natl Canc Ctr Hosp E, Kashiwa, Chiba, Japan
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：492 / 492
页数：1
相关论文
共 50 条
  • [31] Randomized Phase II Trial Comparing Amrubicin With Topotecan in Patients With Previously Treated Small-Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 0402
    Inoue, Akira
    Sugawara, Shunichi
    Yamazaki, Koichi
    Maemondo, Makoto
    Suzuki, Toshiro
    Gomi, Kazunori
    Takanashi, Shingo
    Inoue, Chieko
    Inage, Minoru
    Yokouchi, Hiroshi
    Watanabe, Hiroshi
    Tsukamoto, Toumei
    Saijo, Yasuo
    Ishimoto, Osamu
    Hommura, Fumihiro
    Nukiwa, Toshihiro
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (33) : 5401 - 5406
  • [32] Phase I and pharmacologic study of weekly amrubicin in patients with refractory or relapsed lung cancer: Central Japan Lung Study Group (CJLSG) 0601 trial
    Chiyoe Kitagawa
    Hideo Saka
    Shigehisa Kajikawa
    Kouki Mori
    Masahide Oki
    Ryujiro Suzuki
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 1379 - 1385
  • [33] Phase I and pharmacologic study of weekly amrubicin in patients with refractory or relapsed lung cancer: Central Japan Lung Study Group (CJLSG) 0601 trial
    Kitagawa, Chiyoe
    Saka, Hideo
    Kajikawa, Shigehisa
    Mori, Kouki
    Oki, Masahide
    Suzuki, Ryujiro
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (05) : 1379 - 1385
  • [34] Phase II Study of Arginine Deprivation Therapy With Pegargiminase in Patients With Relapsed Sensitive or Refractory Small-cell Lung Cancer
    Hall, Peter E.
    Ready, Neal
    Johnston, Amanda
    Bomalaski, John S.
    Venhaus, Ralph R.
    Sheaff, Michael
    Krug, Lee
    Szlosarek, Peter W.
    CLINICAL LUNG CANCER, 2020, 21 (06) : 527 - 533
  • [35] EFFICACY OF AMRUBICIN IN PATIENTS WITH REFRACTORY RELAPSED SMALL CELL LUNG CANCER
    Wakuda, Kazushige
    Kenmotsu, Hirotsugu
    Oyakawa, Takuya
    Hisamatsu, Yasushi
    Kimura, Madoka
    Tokito, Takaaki
    Imai, Hisao
    Akamatsu, Hiroaki
    Ono, Akira
    Shukuya, Takehito
    Taira, Tetsuhiko
    Naito, Tateaki
    Murakami, Haruyasu
    Takahashi, Toshiaki
    Endo, Masahiro
    Nakajima, Takashi
    Yamamoto, Nobuyuki
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S493 - S494
  • [36] Lower optimal dose of amrubicin for relapsed small-cell lung cancer: a retrospective study
    Shinji Nakamichi
    Kaoru Kubota
    Fenfei Zou
    Anna Hayashi
    Natsuki Takano
    Naomi Onda
    Masaru Matsumoto
    Akihiko Miyanaga
    Rintaro Noro
    Masahiro Seike
    International Journal of Clinical Oncology, 2023, 28 : 872 - 879
  • [37] Lower optimal dose of amrubicin for relapsed small-cell lung cancer: a retrospective study
    Nakamichi, Shinji
    Kubota, Kaoru
    Zou, Fenfei
    Hayashi, Anna
    Takano, Natsuki
    Onda, Naomi
    Matsumoto, Masaru
    Miyanaga, Akihiko
    Noro, Rintaro
    Seike, Masahiro
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2023, 28 (07) : 872 - 879
  • [38] Retrospective analysis of efficacy and safety of amrubicin in refractory and relapsed small-cell lung cancer
    Shimokawa, Tsuneo
    Shibuya, Masahiko
    Kitamura, Kazuhiro
    Hosomi, Yukio
    Hibino, Suguru
    Ota, Tomohiro
    Iguchi, Mari
    Okamura, Tatsuru
    Gemma, Akihiko
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2009, 14 (01) : 63 - 69
  • [39] Retrospective analysis of efficacy and safety of amrubicin in refractory and relapsed small-cell lung cancer
    Tsuneo Shimokawa
    Masahiko Shibuya
    Kazuhiro Kitamura
    Yukio Hosomi
    Suguru Hibino
    Tomohiro Ota
    Mari Iguchi
    Tatsuru Okamura
    Akihiko Gemma
    International Journal of Clinical Oncology, 2009, 14
  • [40] Phase II study of amrubicin combined with carboplatin for refractory relapsed small-celllung cancer: North Japan Lung Cancer GroupTrial 0802
    Kawashima, Yosuke
    Inoue, Akira
    Sugawara, Shunichi
    Oizumi, Satoshi
    Maemondo, Makoto
    Okudera, Koichi
    Suzuki, Toshiro
    Usui, Kazuhiro
    Harada, Masao
    Morikawa, Naoto
    Hasegawa, Yukihiro
    Saito, Ryota
    Ishimoto, Osamu
    Sakakibara, Tomohiro
    Asahina, Hajime
    Nukiwa, Toshihiro
    RESPIRATORY INVESTIGATION, 2014, 52 (03) : 190 - 194
12345